Prostate Cancer - Results from #22960

ASCO 2013 - Slide Lecture: Prognosis and prediction of outcomes in castration-resistant prostate cancer June 17, 2013

Johnson & Johnson announces definitive agreement to acquire Aragon Pharmaceuticals, Inc June 17, 2013

ASCO 2013 - Slide Lecture: Effect of corticosteroid use at baseline on overall survival in patients receiving abiraterone acetate: Results from a randomized study (COU-AA-301) in metastatic castration-resistant prostate cancer post-docetaxel June 17, 2013

Role of immunotherapy in castration-resistant prostate cancer (CRPC) - Abstract June 14, 2013

Radiotherapy with rectangular fields is associated with fewer clinical failures than conformal fields in the high-risk prostate cancer subgroup: Results from a randomized trial - Abstract June 14, 2013

Sperm banking is of key importance in patients with prostate cancer - Abstract June 14, 2013

Patients undergoing radical prostatectomy have a better survival than the background population - Abstract June 14, 2013

Identification of comorbidities that place men at highest risk of death from androgen deprivation therapy before brachytherapy for prostate cancer - Abstract June 14, 2013

Slide Lecture: Immunotherapy and vaccines in castration resistant prostate cancer: What do we know so far and clinical applications June 14, 2013

Classifying the reasons men consider to be important in prostate-specific antigen (PSA) testing decisions: Evaluating risks, lay beliefs, and informed decisions - Abstract June 14, 2013

A phase II trial of dasatinib in patients with metastatic castration-resistant prostate cancer treated previously with chemotherapy - Abstract June 14, 2013

Phase I pharmacokinetic and biodistribution study with escalating doses of (223)Ra-dichloride in men with castration-resistant metastatic prostate cancer - Abstract June 14, 2013

Plan of the day selection for online image-guided adaptive post-prostatectomy radiotherapy - Abstract June 13, 2013

Current role of surgery for high risk prostate cancer - Abstract June 13, 2013

Cost-benefit of incorporating the detection of circulating prostate cells in a screening programme for prostate cancer - Abstract June 13, 2013

Platinum-based chemotherapy for variant castrate-resistant prostate cancer - Abstract June 13, 2013

Functional and molecular imaging of localized and recurrent prostate cancer - Abstract June 13, 2013

PSA screening and deaths from prostate cancer after diagnosis-A population based analysis - Abstract June 13, 2013

Discussing uncertainty and risk in primary care: Recommendations of a multi-disciplinary panel regarding communication around prostate cancer screening - Abstract June 13, 2013

Unmet needs in the prediction and detection of metastases in prostate cancer - Abstract June 13, 2013

Page 1149 of 1437